Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela C Rieger

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Rambam Maimonides Medical Journal|May 7, 2020
Clinical-based Cell Therapies for Heart Disease-Current and Future StateDarren Turner, Angela C Rieger, Wayne Balkan, et al.
Mechanisms of Ageing and Development|June 11, 2019
Attenuation of frailty in older adults with mesenchymal stem cellsVictoria Florea, Luiza Bagno, Angela C Rieger, et al.
The British Journal of Radiology|July 1, 2022
Non-oncologic incidental uptake on FAPI PET/CT imagingMasatoshi Hotta, Angela C Rieger, Mahbod G Jafarvand, et al.
Journal of the American Heart Association|July 15, 2018
Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated CardiomyopathyBryon A Tompkins, Angela C Rieger, Victoria Florea, et al.
Cardiovascular Research|February 14, 2020
The impact of patient sex on the response to intramyocardial mesenchymal stem cell administration in patients with non-ischaemic dilated cardiomyopathyVictoria Florea, Angela C Rieger, Makoto Natsumeda, et al.
Ebiomedicine|October 26, 2019
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathyAngela C Rieger, Robert J Myerburg, Victoria Florea, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fractionAngela C Rieger, Luiza L Bagno, Alessandro Salerno, et al.
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
Circulation Research|September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Rambam Maimonides Medical Journal|May 7, 2020
Clinical-based Cell Therapies for Heart Disease-Current and Future StateDarren Turner, Angela C Rieger, Wayne Balkan, et al.
Mechanisms of Ageing and Development|June 11, 2019
Attenuation of frailty in older adults with mesenchymal stem cellsVictoria Florea, Luiza Bagno, Angela C Rieger, et al.
The British Journal of Radiology|July 1, 2022
Non-oncologic incidental uptake on FAPI PET/CT imagingMasatoshi Hotta, Angela C Rieger, Mahbod G Jafarvand, et al.
Journal of the American Heart Association|July 15, 2018
Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated CardiomyopathyBryon A Tompkins, Angela C Rieger, Victoria Florea, et al.
Cardiovascular Research|February 14, 2020
The impact of patient sex on the response to intramyocardial mesenchymal stem cell administration in patients with non-ischaemic dilated cardiomyopathyVictoria Florea, Angela C Rieger, Makoto Natsumeda, et al.
Ebiomedicine|October 26, 2019
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathyAngela C Rieger, Robert J Myerburg, Victoria Florea, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fractionAngela C Rieger, Luiza L Bagno, Alessandro Salerno, et al.
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
Circulation Research|September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Pageof 2